Buzz Stocks: GE, SAGE Therapeutics, and AngloGold Ashanti

Today's stocks in the news include General Electric Company (GE), SAGE Therapeutics Inc (SAGE), and AngloGold Ashanti Limited (ADR) (AU)

Jun 9, 2015 at 10:01 AM

NEM
SAGE
GE
AU

Stocks are mixed in early trading, as traders await the latest economic reports and keep an eye trained on Greece. In company news, today's stocks to watch include Dow component General Electric Company (NYSE: GE), pharmaceutical firm SAGE Therapeutics Inc (NASDAQ: SAGE), and mining firm AngloGold Ashanti Limited (ADR) (NYSE: AU).

GE is down 0.2% at $27.19, after agreeing to sell its Antares unit to Canada's largest pension fund. The deal carries a price tag of $12 billion. General Electric Company remains 7.5% higher year-to-date, and since peaking at $28.68 in mid-April, has been consolidating atop its 10-week moving average.

SAGE rocketed to an all-time peak of $89, and was last seen 17.7% higher at $88.43, thanks to positive data from a drug trial. The company's exploratory treatment SAGE-547 showed positive results in four women suffering from postpartum depression. Even before today's data, analysts were in SAGE Therapeutics Inc's bullish corner, as all five brokerage firms consider the equity a "strong buy."

AU is 9.5% higher at $9.55, after Newmont Mining Corp (NYSE: NEM) agreed to purchase AU's Cripple Creek & Victor gold mine in Colorado. The price tag for the acquisition totals $820 million in cash along with future considerations. AU is now poised to close above its 10-day moving average for the first time since May 14. Prior to today, AngloGold Ashanti Limited's 14-day Relative Strength Index (RSI) fell to 23 -- in oversold territory, suggesting a bounce may have been in the cards.

Follow @Schaeffers

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.